Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Basilea Pharmaceutica AG (BPMUF) Return on Tangible Equity data is not available.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$250.93M |
|
$17.49M |
|
$37.80M |
|
$292.79M |
|
$51.75M |
|
$108.95M |
|
$133.48M |
|
$200.79M |
|
$92.01M |
|
$91.58M |
|
$92.01M |
|
-- |
|
| Cash Flow Statement Financials | |
$84.47M |
|
$-1.15M |
|
$-14.95M |
|
$73.06M |
|
$141.49M |
|
$68.42M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Tangible Equity |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|